Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Noosa News21 hours agoTake a look behind the scenes at Noosa Arts Theatre
-
Noosa News21 hours agoWelcome for Greens homeless plan
-
General22 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General19 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails